Cognitive enhancers and hippocampal long-term potentiation in vitro

Behavioural Brain Research

Volumn 83, Issue 1-2, 1997, Pages 45-49

  Kaneko, Shuji ^a   Maeda, Takehiko ^a   Satoh, Masamichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

5 HT3 receptor; AF64A; cognitive enhancer; hippocampus; long term potentiation; muscarinic M1 receptor; somatostatin

Indexed keywords

ANIRACETAM; BIFEMELANE; CARBACHOL; ETHYLCHOLINE MUSTARD AZIRIDINIUM; GRANISETRON; IDEBENONE; INDELOXAZINE; MERCAPTAMINE; MUSCARINIC AGENT; NOOTROPIC AGENT; OTENZEPAD; PHYSOSTIGMINE; PIRACETAM; PIRENZEPINE; SEROTONIN 3 RECEPTOR; SOMATOSTATIN; VINPOCETINE;

ANIMAL TISSUE; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; GUINEA PIG; HIPPOCAMPUS; LONG TERM POTENTIATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031080847     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)86044-5     Document Type: Conference Paper

References (33)

1. 3 receptor antagonist, on cognition in rodents and primates, Pharmacol. Biochem. Behav., 35 (1990) 955-962.
2. [2] Chan-Palay, V., Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on Vibratome sections: coexistence with neuropeptide Y neurons and effects in Alzheimer-type dementia, J. Comp. Neurol., 260 (1987) 201-223.
3. [3] Cumin, R., Bandle, E.F., Gamzu, E. and Haefely, W.E., Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents, Psychopharmacology, 78 (1982) 104-111.
4. [4] DeNoble, V.J., Repetti, S.J., Gelpke, L.W., Wood, L.M. and Keim, K.L., Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats, Pharmacol. Biochem. Behav., 24 (1986) 1123-1128.
5. [5] Fujii, T., Kuraishi, Y., Okada, T. and Satoh, M., Bifemelane induces translocation of protein kinase C in the CA3, but not CA1, region of guinea-pig hippocampus, Can. J. Physiol. Pharmacol., 68 (1990) 413-418.
6. [6] Fujii, T., Kuraishi, Y., Ueda, M. and Satoh, M., Specific binding sites for bifemelane in the hippocampus of the guinea pig, relevant to its pharmacological actions, Neuropharmacology, 30 (1991) 1291-1295.
7. [7] Hopkins, W.F. and Johnston, D., Noradrenergic enhancement of long-term potentiation at mossy fiber synapses in the hippocampus, J. Neurophysiol., 59 (1988) 667-687.
8. [8] Ishihara, K., Katsuki, H., Sugimura, M., Kaneko, S. and Satoh, M., Different drug-susceptibilities of long-term potentiation in three input systems to the CA3 region of the guinea pig hippocampus in vitro, Neuropharmacology, 29 (1990) 487-492.
9. [9] Ishihara, K., Katsuki, H., Sugimura, M. and Satoh, M., Idebenone and vinpocetine augment long-term potentiation in hippocampal slice in the guinea pig, Neuropharmacology, 28 (1989) 569-573.
10. [10] Ito, I. and Sugiyama, H., Roles of glutamate receptors in long-term potentiation at hippocampal mossy fiber synapses, NeuroReport, 2 (1991) 333-336.
11. 3H]MK-801 binding, Eur. J. Pharmacol., 207 (1991) 119-128.
12. 2+ channels: effects of bifemelane and several nootropic agents, Eur. J. Pharmacol., 189 (1990) 51-58.
13. [13] Katsuki, H., Kaneko, S. and Satoh, M., Involvement of postsynaptic G proteins in hippocampal long-term potentiation, Brain Res., 581 (1992) 108-114.
14. [14] Katsuki, H., Kaneko, S., Tajima, A. and Satoh, M., Separate mechanisms of long-term potentiation in two input systems to CA3 pyramidal neurons of rat hippocampal slices as revealed by the whole-cell patch-clamp technique, Neurosci. Res., 12 (1991) 393-402.
15. [15] Köhler, C. and Chan-Palay, V., Somatostatin-like immunoreactive neurons in the hippocampus: an immunocytochemical study in the rat, Neurosci. Lett., 34 (1982) 259-264.
16. 2 muscarinic receptors in guinea pig hippocampal mossy fiber-CA3 synapses, Brain Res., 619 (1993) 324-330.
17. 3 receptors on the induction of LTP in mossy fiber-CA3 system of guinea-pig hippocampal slices, Neurosci. Res., 18 (1994) 277-282.
18. [18] Maeda, T., Kaneko, S. and Satoh, M., Roles of endogenous cholinergic neurons in the induction of long-term potentiation at hippocampal mossy fiber synapses, Neurosci. Res., 20 (1994) 71-78.
19. [19] Matsuoka, N., Kaneko, S. and Satoh, M., A facilitatory role of endogenous somatostatin in long-term potentiation of the mossy fiber-CA3 system in guinea-pig hippocampus, Neurosci. Lett., 129 (1991) 177-180.
20. [20] Matsuoka, N., Kaneko, S. and Satoh, M., Somatostatin augments long-term potentiation of the mossy fiber-CA3 system in guinea-pig hippocampal slices, Brain Res., 553 (1991) 188-194.
21. [21] Matsuoka, N., Maeda, N., Yamazaki, M., Ohkubo, Y. and Yamaguchi, I., Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks, J. Pharmacol. Exp. Ther., 263 (1992) 436-444.
22. [22] Matsuoka, N., Yamaguchi, I. and Satoh, M., Role of somatostatin in the augmentation of hippocampal long-term potentiation by FR121196, a putative cognitive enhancer, Eur. J. Pharmacol., 241 (1993) 27-34.
23. [23] Nakamura, S., Kaneko, S. and Satoh, M., Potentiation of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-selective glutamate receptor function by a nootropic drug, idebenone, Biol. Pharm. Bull., 17 (1994) 70-73.
24. [24] Reubi, J.C. and Maurer, R., Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary, Neuroscience, 15 (1985) 1183-1193.
25. [25] Saito, K., Honda, S., Egawa, M. and Tobe, A., Effects of bifemelane hydrochloride (MCI-2016) on acetylcholine and norepinephrine release from cortical slices of bilaterally carotid-artery-ligated mongolian gerbils, Jpn. J. Pharmacol., 39 (1985) 406-409.
26. [26] Satoh, M., Ishihara, K., Iwama, T. and Takagi, H., Aniracetam augments, and midazolam inhibits, the long-term potentiation in guinea-pig hippocampal slices, Neurosci. Lett., 68 (1986) 216-220.
27. [27] Satoh, M., Ishihara, K. and Katsuki, H., Different susceptibilities of long-term potentiations in CA3 and CA1 regions of guinea pig hippocampal slices to nootropic drugs, Neurosci. Lett., 93 (1988) 236-241.
28. [28] Stegink, A.J., The clinical use of piracetam, a new nootropic drug, Arzneim. Forsch., 22 (1972) 975-977.
29. [29] Sugimura, M., Ishihara, K., Katsuki, H. and Satoh, M., Indeloxazine augments long-term potentiation in the mossy fiber-CA3 system of guinea pig hippocampal slices, J. Pharmacobio-Dyn., 12 (1989) 771-774.
30. [30] Tobe, A., Egawa, M. and Nagai, R., Effect of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (MCI-2016) on the scopolamine-induced deficit of spontaneous alternation behavior in rats, Jpn. J. Pharmacol., 33 (1983) 775-784.
31. [31] Yamamoto, M. and Shimizu, M., Cerebral activating properties of indeloxazine hydrochloride, Neuropharmacology, 26 (1987) 761-770.
32. [32] Yamazaki, N., Take, Y., Nagaoka, A. and Nagawa, Y., Beneficial effect of idebenone (CV-2619) on cerebral ischemia-induced amnesia in rats, Jpn. J. Pharmacol., 36 (1984) 349-356.
33. [33] Zalutsky, R.A. and Nicoll, R.A., Comparison of two forms of long-term potentiation in single hippocampal neurons, Science, 248 (1990) 1619-1624.